San Francisco, California, and Houston, TX, May 16, 2012 —
Avalanche Biotechnologies, Inc. and Lonza announced their major global manufacturing collaboration to use Virovek’s patented technologyto produce AAV vectors for gene therapy studies.
San Francisco, California, and Houston, TX, May 16, 2012 —
Avalanche Biotechnologies, Inc. and Lonza announced their major global manufacturing collaboration to use Virovek’s patented technologyto produce AAV vectors for gene therapy studies.